首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1918110

骨科生物製劑市場－2026-2031年預測

Orthobiologics Market - Forecast from 2026 to 2031

出版日期: 2026年01月14日 | 出版商:

Knowledge Sourcing Intelligence | 英文 152 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

骨科生物製劑市場預計將從 2025 年的 68.16 億美元成長到 2031 年的 88.77 億美元，複合年成長率為 4.5%。

骨科生物製劑市場正經歷顯著成長，這主要得益於臨床需求、人口趨勢和技術創新三者的共同推動。這些產品由生物來源材料製成，用於治療肌肉骨骼疾病，在治療急性和慢性骨骼、關節和軟組織疾病方面變得日益重要。全球肌肉骨骼疾病的增加、創傷性損傷的增加以及對先進生物治療方法的關注，都進一步促進了市場擴張。

骨骼疾病和肌肉骨骼疾病在全球日益普遍，是推動市場發展的關鍵因素。骨關節炎、骨質疏鬆症和慢性關節疼痛等疾病是全球範圍內導致殘疾的重要且不斷成長的原因。如此高的發病率造就了龐大且持續的患者群體，他們需要有效的整形外科干預措施，從而產生了對能夠促進癒合和緩解疼痛的骨科生物製劑的潛在需求。

同時，運動相關傷害和道路交通事故發生率的上升也是市場成長的主要驅動力。這些損傷通常會導致骨骼、關節和軟組織嚴重受損，需要先進的修復和再生治療。全球範圍內全年此類損傷的大量發生，確保了對用於外科手術和治療的骨科生物製劑產品持續且顯著的需求，這些產品旨在恢復功能並加速康復。

人口結構變化也對市場產生了顯著影響。全球人口老化是主要因素之一，老年人尤其容易罹患骨關節炎和骨質疏鬆症。這一人口趨勢與需要整形外科治療的疾病發生率的增加直接相關，從長遠來看，這將擴大骨科生物製劑的目標患者群體。此外，可支配收入的增加和生活水準的提高，尤其是在開發中國家，正在擴大人們獲得先進醫療服務的機會。隨著患者尋求更有效、更舒適的治療方案，對先進骨科生物製劑的需求也預計將隨之成長。

在企業研發和政府主導的各項措施的支持下，技術進步是推動市場發展的關鍵因素。大量的公共和私人投資正湧入下一代再生醫學技術的研究領域，包括用於骨骼和軟骨再生的注射解決方案。這種對創新的執著追求不斷拓展骨科生物製劑的治療能力和臨床應用，從而催生出充滿活力的新產品和治療方法。

北美作為關鍵市場，其特點是肌肉骨骼疾病（尤其是關節炎）高發生率、監管和臨床基礎設施完善，以及許多大型醫療設備公司的存在。該地區對技術應用的高度重視和成熟的醫療保健生態系統鞏固了其主導地位。

亞太地區已成為成長最快的市場之一。這一成長主要得益於高發生率的道路交通事故、不斷成長的醫療費用支出以及政府投資推動的持續技術進步。該地區龐大的人口基數和快速發展的醫療基礎設施為市場擴張提供了巨大的機會。

競爭格局包括Alphatec Spine、Earthtrex和Bioventus等專業公司，它們專注於開發脊椎手術、關節修復和疼痛管理的綜合解決方案，並透過持續的產品創新來維持市場地位。該行業每年推出的新產品數量眾多，反映出競爭激烈且創新主導的環境，旨在改善手術效果並滿足肌肉骨骼疾病患者的複雜需求。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2021-2025 年）和預測資料（2026-2031 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 德國
- 法國
- 英國
- 西班牙
- 義大利
- 其他
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 其他
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 印尼
- 泰國
- 其他

第9章：競爭格局與分析

主要企業和策略分析
市佔率分析
企業合併、協議、商業合作
競爭對手儀錶板

第10章：公司簡介

Alphatec Spine, Inc.
Arthrex Inc.
Bioventus LLC
Exactech, Inc.
Integra Lifesciences
Medtronic Plc
MTF Biologics
Zimmer Biomet
Stryker Corporation
Johnson & Johnson
NuVasive

第11章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要收益
分析方法
簡稱

簡介目錄

Product Code: KSI061615581

The orthobiologics market is projected to expand at a 4.5% CAGR, attaining USD 8.877 billion in 2031 from USD 6.816 billion in 2025.

The orthobiologics market is experiencing significant growth, driven by the convergence of clinical demand, demographic trends, and technological innovation. These products, which are derived from biological substances and used to treat musculoskeletal conditions, are becoming integral to the management of acute and chronic bone, joint, and soft tissue disorders. The market's expansion is underpinned by a rising global burden of musculoskeletal disease, an increasing volume of traumatic injuries, and a shift towards advanced, biologically-driven treatment modalities.

A primary market driver is the escalating global prevalence of bone diseases and musculoskeletal defects. Conditions such as osteoarthritis, osteoporosis, and chronic joint pain represent a substantial and growing source of disability worldwide. This high prevalence establishes a large and sustained patient population in need of effective orthopedic interventions, creating a foundational demand for orthobiologic solutions that can enhance healing and alleviate pain.

Concurrently, the rising incidence of sports-related and road traffic injuries is a major contributor to market growth. These traumatic events frequently result in significant damage to bones, joints, and soft tissues, necessitating advanced reparative and regenerative treatments. The high annual global volume of such injuries ensures a consistent and significant demand for orthobiologic products used in surgical and therapeutic applications to restore function and accelerate recovery.

Demographic shifts are also profoundly influencing the market. The global aging population is a key factor, as older adults are disproportionately affected by degenerative joint diseases and osteoporosis. This demographic trend directly correlates with an increased incidence of conditions requiring orthopedic care, thereby expanding the addressable patient base for orthobiologic therapies over the long term. Furthermore, rising disposable incomes and improving living standards, particularly in developing economies, are enabling greater access to advanced medical treatments. As patients seek more effective and comfortable care, the demand for sophisticated orthobiologic solutions is expected to rise correspondingly.

Technological advancement, supported by both corporate R&D and governmental initiatives, is a critical force propelling the market forward. Significant public and private investments are being channeled into research focused on next-generation regenerative technologies, including injectable solutions for bone and cartilage regeneration. This commitment to innovation is continuously expanding the therapeutic capabilities and clinical applications of orthobiologics, fostering a dynamic pipeline of new products and treatment approaches.

Geographically, North America is a dominant market, characterized by a high prevalence of arthritis and other musculoskeletal conditions, a robust regulatory and clinical infrastructure, and the presence of leading medical device companies. The region's strong focus on technological adoption and its mature healthcare ecosystem consolidate its leadership position.

The Asia-Pacific region is emerging as one of the fastest-growing markets. This growth is fueled by a high incidence of road traffic accidents, increasing healthcare expenditure, and ongoing technological advancements supported by government investment. The region's large population and rapidly developing healthcare infrastructure present a substantial opportunity for market expansion.

The competitive landscape includes specialized players such as Alphatec Spine, Arthrex, and Bioventus. These companies maintain their market positions through continuous product innovation, with a focus on developing comprehensive solutions for spine surgery, joint restoration, and pain management. The industry's high rate of new product introductions each year reflects a intensely competitive and innovation-driven environment, aimed at improving surgical outcomes and addressing the complex needs of patients with musculoskeletal disorders.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Orthobiologics Market Segmentation:

By Product
Stem Cell Therapy
PRP
Viscosupplementation
Bone Marrow Aspirate Concentrate (BMAC)
Others
By Application
Ligament & Tendon Injury
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Others
By End-User
Hospitals
Orthopedic Clinics
Others
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Italy
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL ORTHOBIOLOGICS MARKET BY

5.1. Introduction
5.2. Stem Cell Therapy
5.3. PRP
5.4. Viscosupplementation
5.5. Bone Marrow Aspirate Concentrate (BMCA)
5.6. Others

6. GLOBAL ORTHOBIOLOGICS MARKET BY APPLICATION

6.1. Introduction
6.2. Ligament & Tendon Injury
6.3. Osteoarthritis & Degenrative Arthritis
6.4. Spinal Fusion
6.5. Others

7. GLOBAL ORTHOBIOLOGICS MARKET BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Orthopedo Clinics
7.4. Others

8. GLOBAL ORTHOBIOLOGICS MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Italy
- 8.4.6. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others